Reece Caldwell
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Actinomycin D versus etoposide, methotrexate, actinomycin D/cyclophosphamide, and vincristine as second-line treatment in low-risk gestational trophoblastic neoplasia with primary methotrexate resistance.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 18, 2026
Malignant Adult Ovarian Germ Cell Tumors: An International Multicenter Study to Identify Relevant Prognostic Risk Factors for Stage IC and Beyond.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 06, 2026
Comparison of efficacy and toxicity of 2 dactinomycin (ACTD) regimens in the second-line treatment of low-risk gestational trophoblastic neoplasia: a retrospective study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 02, 2025
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial.
Journal: Nature medicine
Published: December 12, 2024
Monitoring complete hydatidiform molar pregnancies after normalisation of human chorionic gonadotrophin: national retrospective population study.
Journal: BMJ medicine
Published: July 11, 2024
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.
Journal: Nature
Published: May 23, 2023
Targeting homologous recombination deficiency in uterine leiomyosarcoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 14, 2023
First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors.
Journal: Cancer discovery
Published: June 19, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026